Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,037.82, giving the company a market capitalization of 977.36B. It carries a P/E multiple of 36.68 and pays a dividend yield of 61.1%.
On 2026-05-21, Eli Lilly(LLY) stock traded between a low of $1,015.05 and a high of $1,045.57. Shares are currently priced at $1,037.82, which is +2.2% above the low and -0.7% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.61M, compared to an average daily volume of 3.05M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
U.S. pharmaceutical giant Eli Lilly (LLY) says its next-generation weight-loss drug has cleared a late-stage clinical trial in patients who are obese. Start a...
Biotech and Pharma Eli Lilly’s New GLP-1 Drug Looks Like a Weight-Loss Powerhouse in New Trial In this article LLY NVO Eli Lilly shares have fallen around 5% so...
Truist keeps the firm’s Buy rating and a $1,281 price target on Eli Lilly (LLY). The company’s retatrutide Phase 3 clinical trial data in obesity announced this...
Analyst ratings
85%
of 33 ratingsMore LLY News
Key Points Eli Lilly dominates the weight loss drug market and competes with fellow pharma giant Novo Nordisk. Viking is studying promising weight loss candid...
A view of the New York Stock Exchange after Eli Lilly’s team rang the opening bell in New York on May 11. (Photo by ANGELA WEISS / AFP via Getty Images) Eli Li...
An investigational drug developed by Eli Lilly delivered clinically meaningful weight loss in a trial. Mike Blake / Reuters An investigational drug developed b...
Key Points Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses....
Key Points Demand for weight-loss drugs has exploded, with material differentiation among the players in the niche. There's a clear leader, but that may not b...
Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...
U.S. pharmaceutical company Eli Lilly (LLY) has acquired Engage Biologics for $202 million in cash. Start a conversation with TipRanks’ trusted, data-backed in...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.